Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Operating Expenses | 3,817 | 3,614 | 2,647 | 2,540 | 3,116 |
| Operating Income | -3,817 | -3,614 | -2,647 | -2,540 | -3,116 |
| Interest Expense | 7 | 9 | 9 | 8 | 12 |
| Other Income | 63 | 44 | 50 | 48 | 42 |
| Pre-tax Income | -3,761 | -3,578 | -2,606 | -2,501 | -3,086 |
| Net Income Continuous | -3,761 | -3,578 | -2,606 | -2,501 | -3,086 |
| Net Income | $-3,761 | $-3,578 | $-2,606 | $-2,501 | $-3,086 |
| EPS Basic Total Ops | -7,518.74 | -7,914.46 | -5,540.12 | -5,935.85 | -8,705.91 |
| EPS Basic Continuous Ops | -7,453.51 | -7,846.87 | -5,320.02 | -5,937.75 | -8,887.86 |
| EPS Diluted Total Ops | -7,518.74 | -7,914.46 | -5,540.12 | -5,935.85 | -8,705.91 |
| EPS Diluted Continuous Ops | -7,453.51 | -7,846.87 | -5,320.02 | -5,937.75 | -8,887.86 |
| EBITDA(a) | $-3,701 | $-3,514 | $-2,552 | $-2,452 | $-3,021 |